JPS6481A - H2-receptor antagonist compound - Google Patents

H2-receptor antagonist compound

Info

Publication number
JPS6481A
JPS6481A JP62336738A JP33673887A JPS6481A JP S6481 A JPS6481 A JP S6481A JP 62336738 A JP62336738 A JP 62336738A JP 33673887 A JP33673887 A JP 33673887A JP S6481 A JPS6481 A JP S6481A
Authority
JP
Japan
Prior art keywords
acid
receptor antagonist
expressed
formula
org
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62336738A
Other languages
English (en)
Other versions
JPH0181A (ja
Inventor
Rodes Montserrat Ballester
Francisco Eugenio Palomo-Nicolau
Oller Jose Maria Solis
Coll Antonio Luis Palomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barisintex SA
Centro Marga Para la Investigacion SA
Original Assignee
Barisintex SA
Centro Marga Para la Investigacion SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barisintex SA, Centro Marga Para la Investigacion SA filed Critical Barisintex SA
Publication of JPS6481A publication Critical patent/JPS6481A/ja
Publication of JPH0181A publication Critical patent/JPH0181A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62Three oxygen atoms, e.g. ascorbic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP62-336738A 1987-01-07 1987-12-28 H2−受容体拮抗体化合物 Pending JPH0181A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8719009A IT1215325B (it) 1987-01-07 1987-01-07 Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
IT19009A/87 1987-01-07

Publications (2)

Publication Number Publication Date
JPS6481A true JPS6481A (en) 1989-01-05
JPH0181A JPH0181A (ja) 1989-01-05

Family

ID=

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888595A (en) * 1986-11-13 1989-12-19 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Acquisition signal transmitter
US4954642A (en) * 1985-11-15 1990-09-04 Nippon Kayaku Kabushiki Kaisha Forskolin compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954642A (en) * 1985-11-15 1990-09-04 Nippon Kayaku Kabushiki Kaisha Forskolin compounds
US4888595A (en) * 1986-11-13 1989-12-19 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Acquisition signal transmitter

Also Published As

Publication number Publication date
IT1215325B (it) 1990-02-08
EP0277900A3 (en) 1989-11-08
EP0277900A2 (en) 1988-08-10
IT8719009A0 (it) 1987-01-07
KR880009004A (ko) 1988-09-13

Similar Documents

Publication Publication Date Title
CA2328780A1 (en) Dihydropyrimidines
ES8300112A1 (es) Un procedimiento para preparar compuestos de cefem .
HU903963D0 (en) Condensed heterocyclic compounds, their preparation and utilization
CA2036905A1 (en) Condensed thiazole compounds, their production and use
ES8705892A1 (es) Un metodo para preparar derivados de cefem
ZA839382B (en) New substituted 1,4-dihydropyridines,process for their preparation and their use as medicaments
JPS55115892A (en) 3-phosphonocephalosporanic acid derivative, its preparation, and medicine containing the same
EP0248645A3 (en) Cephalosporin compounds
WO1997031016A3 (en) New inhibitors of sh2-mediated processes
JPS6481A (en) H2-receptor antagonist compound
JPS57183738A (en) Aromatic carboxylic acid derivative
WO1991008737A3 (en) Pharmacologically active amide carboxylate derivatives
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
JPS5212141A (en) Novel amino benzoic acid derivatives, their preparation, and pharmaceu tical compositions therefrom
JPS6442475A (en) Thiazolidine derivative
JPS57183768A (en) 4-methyl-5-(o-carboxyphenyl)carbamoylthiazole derivative and its preparation
KR960014780B1 (en) Dental plaque inhibitor composition and its preparation
JPS5716852A (en) Nitrile derivative, its preparation, and fibrosis suppressing agent containing the same
JPS56142282A (en) Penem-3-carboxylic acid derivative and its preparation
JPS5692261A (en) Novel cyclohexanecarboxylic derivative and its preparation
JPS55104266A (en) Novel pyridone derivative
JPS5772981A (en) 1,8-naphthyridine derivative and its salt
IE43501L (en) Hydroxyacids.
JPS5511503A (en) Condensed heterocyclic compound
JPS5520740A (en) Aminoalkoxybibenzyl and its acid addition salt